open access

Vol 84, No 1 (2016)
ORIGINAL PAPERS
Published online: 2015-11-24
Submitted: 2014-11-02
Accepted: 2015-10-01
Get Citation

Effect of disease acceptance on quality of life in patients with chronic obstructive pulmonary disease (COPD).

Beata Jankowska-Polańska, Maria Kasprzyk, Anna Chudiak, Izabella Uchmanowicz
DOI: 10.5603/PiAP.a2015.0079
·
Pneumonol Alergol Pol 2016;84(1):3-10.

open access

Vol 84, No 1 (2016)
ORIGINAL PAPERS
Published online: 2015-11-24
Submitted: 2014-11-02
Accepted: 2015-10-01

Abstract

Introduction: Despite the advances in medicine, COPD is still leading, incurable and chronic respiratory disease. It greatly restricts the functioning of patients in terms of physical, emotional and social aspects, reducing significantly their quality of life. The study into quality of life in patients with COPD is becoming increasingly important as a valuable complement to the assessment of clinical status of the patient, the effects of therapy, effectiveness of educational programs, clinical evaluation of drugs, including the patient’s acceptance of the disease and treatment. Acceptance or lack thereof, can affect the healing process, result in the lack of cooperation and conscious participation of the patient in the therapeutic process, correlate negatively with different variables of treatment and may lead to the lack of cooperation between the patient and a therapeutic team.

The aim of this study was to determine the correlation of acceptance of disease with quality of life in patients with chronic obstructive pulmonary disease.

Material and methods: The study included 105 patients (including 29 women). Analysis was used to examine the medical records, the Acceptance of Illness Scale (AIS) and the World Health Organization Quality of Life-BREF (WHOQOL-Bref).The results showed a significantly higher quality of life, in all domains of the questionnaire in patients with COPD who accept their illness to a high degree (AIS > 29). In the physical health domain, group I (lack of acceptance AIS 8−18) won 23.4 ± 13.7, group II (mean acceptance AIS 19−29) 47.9 ± 11.2, group III (high acceptance AIS > 29) 68.9 ± 12.8; p < 0.001. In the psychological domain, group I achieved 40.4 ± 9.2; group II 63.9 ± 9.7; group III 74.9 ± 10.1, in the social relationships domain, group I 48.4 ± 12.5; group II, 69.6 ± 12.7; group III 74.9 ± 10.1, in the environmental domain, group I 45.4 ± 10.7; group II, 62.3 ± 11.6; group III 71.5 ± 10.0) (p < 0.001). Patients with COPD highest rated their quality of life in the domain of social relationships 46.7 ± 19.6, and lowest in the domain of physical health 68.8 ± 18.4.

Conclusions: Acceptance of the disease has a significant impact on the level of assessment of quality of life in patients with COPD — the higher acceptance, the higher rating of quality of life.

Abstract

Introduction: Despite the advances in medicine, COPD is still leading, incurable and chronic respiratory disease. It greatly restricts the functioning of patients in terms of physical, emotional and social aspects, reducing significantly their quality of life. The study into quality of life in patients with COPD is becoming increasingly important as a valuable complement to the assessment of clinical status of the patient, the effects of therapy, effectiveness of educational programs, clinical evaluation of drugs, including the patient’s acceptance of the disease and treatment. Acceptance or lack thereof, can affect the healing process, result in the lack of cooperation and conscious participation of the patient in the therapeutic process, correlate negatively with different variables of treatment and may lead to the lack of cooperation between the patient and a therapeutic team.

The aim of this study was to determine the correlation of acceptance of disease with quality of life in patients with chronic obstructive pulmonary disease.

Material and methods: The study included 105 patients (including 29 women). Analysis was used to examine the medical records, the Acceptance of Illness Scale (AIS) and the World Health Organization Quality of Life-BREF (WHOQOL-Bref).The results showed a significantly higher quality of life, in all domains of the questionnaire in patients with COPD who accept their illness to a high degree (AIS > 29). In the physical health domain, group I (lack of acceptance AIS 8−18) won 23.4 ± 13.7, group II (mean acceptance AIS 19−29) 47.9 ± 11.2, group III (high acceptance AIS > 29) 68.9 ± 12.8; p < 0.001. In the psychological domain, group I achieved 40.4 ± 9.2; group II 63.9 ± 9.7; group III 74.9 ± 10.1, in the social relationships domain, group I 48.4 ± 12.5; group II, 69.6 ± 12.7; group III 74.9 ± 10.1, in the environmental domain, group I 45.4 ± 10.7; group II, 62.3 ± 11.6; group III 71.5 ± 10.0) (p < 0.001). Patients with COPD highest rated their quality of life in the domain of social relationships 46.7 ± 19.6, and lowest in the domain of physical health 68.8 ± 18.4.

Conclusions: Acceptance of the disease has a significant impact on the level of assessment of quality of life in patients with COPD — the higher acceptance, the higher rating of quality of life.

Get Citation

Keywords

chronic obstructive pulmonary disease; quality of life; the level acceptance of disease

About this article
Title

Effect of disease acceptance on quality of life in patients with chronic obstructive pulmonary disease (COPD).

Journal

Advances in Respiratory Medicine

Issue

Vol 84, No 1 (2016)

Pages

3-10

Published online

2015-11-24

DOI

10.5603/PiAP.a2015.0079

Bibliographic record

Pneumonol Alergol Pol 2016;84(1):3-10.

Keywords

chronic obstructive pulmonary disease
quality of life
the level acceptance of disease

Authors

Beata Jankowska-Polańska
Maria Kasprzyk
Anna Chudiak
Izabella Uchmanowicz

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Pneumonologia i Alergologia Polska dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl